Antje Knöll

Summary

Affiliation: University of Regensburg
Country: Germany

Publications

  1. ncbi Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany
    A Knoll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Germany
    J Med Virol 59:14-8. 1999
  2. ncbi Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature
    A Knoll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Germany
    Lab Invest 81:251-62. 2001
  3. ncbi Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR)
    Antje Knöll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Germany
    J Med Virol 67:259-66. 2002
  4. ncbi Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas
    Antje Knöll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, D 93042 Regensburg, Germany
    Oncol Rep 10:487-91. 2003
  5. ncbi Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation
    A Knoll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany
    Bone Marrow Transplant 33:925-9. 2004
  6. ncbi Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation
    Antje Knöll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, D 93042 Regensburg, Germany
    Transplantation 79:1631-3. 2005
  7. ncbi Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance
    Antje Knöll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, D 93042 Regensburg, Germany
    World J Gastroenterol 12:1255-60. 2006
  8. ncbi Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor
    A Knoll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany
    J Viral Hepat 14:478-83. 2007
  9. ncbi Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products
    Annelie Plentz
    Institute of Medical Microbiology and Hygiene and the Department of Haematology and Oncology, University of Regensburg, Germany
    Transfusion 45:1811-5. 2005

Detail Information

Publications9

  1. ncbi Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany
    A Knoll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Germany
    J Med Virol 59:14-8. 1999
    ..In conclusion, HBV precore mutants are common in Germany and can therefore present a diagnostic problem for serological testing. However, precore mutants do not appear to have a detrimental effect on the course of chronic HBV infection...
  2. ncbi Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature
    A Knoll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Germany
    Lab Invest 81:251-62. 2001
    ..Based on a review of the current literature about nosocomial HCV infection and HCV infection in children, hypotheses for possible means of transmission in this outbreak are discussed...
  3. ncbi Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR)
    Antje Knöll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Germany
    J Med Virol 67:259-66. 2002
    ..1 x 10(12) copies/ml) compared to the corresponding maternal blood samples...
  4. ncbi Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas
    Antje Knöll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, D 93042 Regensburg, Germany
    Oncol Rep 10:487-91. 2003
    ..These data provide no evidence for a causative role of the human polyomaviruses BKV and JCV in the development of tumors of the renal pelvis and the kidney...
  5. ncbi Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation
    A Knoll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany
    Bone Marrow Transplant 33:925-9. 2004
    ..A highly sensitive HBV-DNA assay (TaqMan-PCR) allowed early identification of the individual patients at risk...
  6. ncbi Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation
    Antje Knöll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, D 93042 Regensburg, Germany
    Transplantation 79:1631-3. 2005
    ..In conclusion, subclinical reactivation of HBV infection was detected in a significant proportion of HBsAg-negative solid-organ-transplant recipients...
  7. ncbi Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance
    Antje Knöll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, D 93042 Regensburg, Germany
    World J Gastroenterol 12:1255-60. 2006
    ..To investigate the prevalence and clinical significance of "anti-HBc alone" in an unselected population of patients and employees of a university hospital in southern Germany...
  8. ncbi Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor
    A Knoll
    Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany
    J Viral Hepat 14:478-83. 2007
    ..In conclusion, the risk of reactivation of a resolved HBV infection is close to 100% in allogeneic stem cell recipients and vaccination of the donor does not always warrant reliable protection...
  9. ncbi Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products
    Annelie Plentz
    Institute of Medical Microbiology and Hygiene and the Department of Haematology and Oncology, University of Regensburg, Germany
    Transfusion 45:1811-5. 2005
    ..Primary infection with parvovirus B19 shows a wide variety of disease manifestation. In immunocompromised patients, symptoms are severe and viral clearance is delayed or missing...